| Management target | Revenue 100.0% FY30 |
|---|
| Revenue growth | 20.01% YoY in Q1 FY27. |
|---|---|
| Margins | EBITDA margin 24.6%; expected to sustain north of 20%. |
| Order book | Long-term contracts with Givaudan, P&G, and Henkel. |
| Demand visibility | Broad-based demand across domestic and export markets. |
| Management confidence | High; citing resilience and structural business strength. |
Growth
Revenue grew 20.01% YoY to Rs 681.42 Cr; Net Profit surged 35.97% YoY to Rs 84.21 Cr.
Outlook
Targeting Rs 5,000 Cr revenue and Rs 1,000 Cr+ EBITDA by FY29-30. Expansion projects operational by H2 2028.
Risks
One-off fire loss of Rs 2.78 Cr; adverse global headwinds and potential supply chain vulnerabilities mentioned.
Last quarter's promises, checked
Delivered
- Guided 20% revenue growth → delivered 20.01% (= BEAT)
- Guided 20%+ EBITDA margins → delivered 24.6% (= BEAT)
- Guided PRIGIV JV profitability → delivered Q1 FY27 profits (= BEAT)
Partly delivered
- Guided Phase 1 capex completion by June 30, 2026 → delivered operational ramp-up in Q1 FY27 (= PARTIAL)
Investor Presentation filed with BSE, NSE: PRIVISCL. Summary written with AI assistance from the document.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,506.30
- Market cap
- ₹13,697 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 39.1×Sector 37.2×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 1.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Capital Structure Change
SBI Mutual Fund sold 18,400 shares of Privi Speciality Chemicals Ltd via open market, reducing its stake from 7.3905% to 7.3434%.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals announced an NCLT-convened meeting of equity shareholders for October 27, 2026, to consider the proposed Scheme of Amalgamation involving two transferor companies.
Privi Speciality Chemicals Annual General Meeting
Privi Speciality Chemicals Ltd held its 41st Annual General Meeting on August 7, 2026. The meeting covered financial adoption, dividend declaration, and director appointments.
Privi Speciality Chemicals Earnings Call Transcript: Key Takeaways
Privi reports 19.22% revenue growth and steady 24% EBITDA margins. Management maintains a confident outlook on expansion despite gross margin compression from high raw material costs compared to last year's low-cost base.
- Call
- Guides 100% growth
Privi Speciality Chemicals Q1 FY27 Results: Net Profit ₹82.8 Cr, Up 43.7% YoY
Privi Speciality Chemicals Ltd reported revenue from operations of ₹666.2 Cr (+19.2% YoY) and net profit of ₹82.8 Cr (+43.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹82.8 Cr · +43.7% YoY
Privi Speciality Chemicals Board Meeting Date
Privi Speciality Chemicals Ltd has scheduled a Board Meeting on July 30, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.